- Home
- VICR vs RXRX Comparison
VICR vs RXRX Comparison
Compare VICR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VICR
- RXRX
- Stock Information
- Founded
- VICR 1981
- RXRX 2013
- Country
- VICR United States
- RXRX United States
- Employees
- VICR N/A
- RXRX N/A
- Industry
- VICR Industrial Machinery/Components
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- VICR Technology
- RXRX Health Care
- Exchange
- VICR Nasdaq
- RXRX Nasdaq
- Market Cap
- VICR 1.9B
- RXRX 2.0B
- IPO Year
- VICR N/A
- RXRX 2021
- Fundamental
- Price
- VICR $45.20
- RXRX $6.54
- Analyst Decision
- VICR Hold
- RXRX Buy
- Analyst Count
- VICR 2
- RXRX 5
- Target Price
- VICR $43.00
- RXRX $7.00
- AVG Volume (30 Days)
- VICR 273.5K
- RXRX 33.1M
- Earning Date
- VICR 07-22-2025
- RXRX 08-07-2025
- Dividend Yield
- VICR N/A
- RXRX N/A
- EPS Growth
- VICR N/A
- RXRX N/A
- EPS
- VICR 0.51
- RXRX N/A
- Revenue
- VICR $369,154,000.00
- RXRX $59,790,000.00
- Revenue This Year
- VICR $14.66
- RXRX $23.85
- Revenue Next Year
- VICR $15.24
- RXRX $43.06
- P/E Ratio
- VICR $88.07
- RXRX N/A
- Revenue Growth
- VICR N/A
- RXRX 29.32
- 52 Week Low
- VICR $34.27
- RXRX $3.79
- 52 Week High
- VICR $65.70
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- VICR 45.93
- RXRX 69.88
- Support Level
- VICR $47.38
- RXRX $5.13
- Resistance Level
- VICR $49.03
- RXRX $7.15
- Average True Range (ATR)
- VICR 1.43
- RXRX 0.43
- MACD
- VICR -0.04
- RXRX 0.11
- Stochastic Oscillator
- VICR 28.41
- RXRX 74.04
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.